Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Investment Programs topic
No spam. Unsubscribe anytime.
HPC highlights maternal remote‑monitoring investment and proposes hospital‑to‑home pilot with evaluation focus
Summary
HPC staff described a $1.5M HeartBP program to expand remote blood‑pressure monitoring for birthing people and proposed a Pathways hospital‑to‑home pilot (up to seven awards at ~$300,000 each) emphasizing rigorous evaluation, dissemination and sustainability.
Get email alerts on the Investment Programs topic
No spam. Unsubscribe anytime.
Executive Director David Seltz and Taylor Bungo, director on the healthcare transformation team, reviewed the HPC's investment portfolio and two specific initiatives.
Seltz recapped the commission's history as a grantmaker and investor, noting roughly $90 million invested across multiple programs and more than 200,000 patient lives reached. "Our investments test evidence‑based models and aim to surface insights that inform broader policy," he said.
Taylor Bungo described HeartBP (Hypertensive disorders Equitably Addressed with Remote Technology for Birthing People): a $1.5 million investment spanning five awardees over a 30‑month performance period to deploy remote blood‑pressure monitoring, mitigate inequities, reduce avoidable readmissions, and collect mixed methods evaluation data. Bungo said awardees are working with Medicaid reimbursement leads and technical assistance partners to support scale and sustainability.
Bungo also introduced Pathways (Promoting Appropriate Transitions to Home), a proposed pilot to embed home and community‑based services liaisons in hospitals via partnerships with ASAPs. The proposal anticipates up to seven awards at about $300,000 per award for two years, focused on timely discharge, institutional diversion and an evaluation to demonstrate sustainability. Commissioners asked for details on evaluation metrics and design; Commissioner Ericson urged rigorous designs that could identify causal effects and suggested randomization where feasible. Bungo and other staff said evaluation and dissemination are core program components, with planned qualitative and quantitative measures (length of stay, readmissions, patient/staff experience) and partnerships for technical assistance.
Commissioners emphasized sustainability and scaling: they asked how successful pilots would be translated into payment or policy changes (Medicaid reimbursement, insurer supports) and urged clear dissemination paths so programs can be adopted beyond initial awardees. HPC staff said the agency will coordinate with state agencies and potential funders to make the case for scalable reimbursement and policy changes if evaluations show value.

